|1||NCT00043225||Recruiting||The Role of Bacteria and Genetic Variations in Cystic Fibrosis||
||NIH||200||All||9 Years to 80 Years (Child, Adult, Senior)||NCT00043225||010198
|June 20, 2001||August 7, 2002||November 27, 2017||
|2||NCT01111383||Completed||A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®||
||209||All||6 Years and older (Child, Adult, Senior)||NCT01111383||CMA-0631-PR-0010 Extension||CT03Ext||September 2009||May 2011||May 2011||April 27, 2010||November 21, 2011||
† Study has passed its completion date and status has not been verified in more than two years.